Raiffeisen Bank International’s Pfizer PFE Stock Holding History

Raiffeisen Bank International’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.7M	Buy	1,398,194 +18,800	+1%	+$492K	0.4%	63
2026 Q1	$38.7M	Buy	1,379,394 +1,308,133	+1,836%	+$34.8M	0.56%	45
2025 Q4	$1.78M	Sell	71,261 -3,989	-5%	-$101K	0.02%	264
2025 Q3	$1.79M	Buy	75,250 +22,478	+43%	+$555K	0.02%	250
2025 Q2	$1.28M	Sell	52,772 -1,059	-2%	-$24.7K	0.02%	249
2025 Q1	$1.36M	Buy	53,831 +14,937	+38%	+$391K	0.02%	243
2024 Q4	$1.03M	Buy	+38,894	New	+$1.05M	0.02%	269

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Raiffeisen Bank International's PFE Position: Q2 2026 in Review

Raiffeisen Bank International increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $492K and bringing the position to 1,398,194 shares worth $33.7M. The position accounts for 0.4% of the portfolio, ranked #63.

Raiffeisen Bank International first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $38.7M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Raiffeisen Bank International held 1,398,194 shares of Pfizer worth $33.7M as of Q2 2026.
Raiffeisen Bank International bought 18,800 Pfizer shares in Q2 2026, an estimated $492K.
Pfizer made up 0.4% of Raiffeisen Bank International's portfolio in Q2 2026, its #63 holding.
Raiffeisen Bank International first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Raiffeisen Bank International's Pfizer position peaked at $38.7M in Q1 2026.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.